-transparent.png){kind=logo}
Comparing the radiotherapy data of two groups of patients with non-metastatic Ewing sarcoma, we came to the following conclusions: intensive chemotherapy does not substitute for effective radiotherapy. Irradiation fields should be large enough to include the whole affected bone and the entire extra-osseous compartments, exempting only uninvolved epiphyses. Marginal recurrences are a major risk of the shrinking field technique. Single doses per fraction should be high and the total dose raised to the point of maximal irradiation tolerance of normal tissues.
Related Publications
G Prindull, and
H Jürgens, and
F Jentsch, and
R Sauer, and
U Lasson
June 2013,
American journal of clinical oncology,
G Prindull, and
H Jürgens, and
F Jentsch, and
R Sauer, and
U Lasson
August 2007,
Pediatric blood & cancer,
G Prindull, and
H Jürgens, and
F Jentsch, and
R Sauer, and
U Lasson
January 2014,
Sarcoma,
G Prindull, and
H Jürgens, and
F Jentsch, and
R Sauer, and
U Lasson
October 1997,
American journal of ophthalmology,
G Prindull, and
H Jürgens, and
F Jentsch, and
R Sauer, and
U Lasson
January 1994,
Klinische Padiatrie,
G Prindull, and
H Jürgens, and
F Jentsch, and
R Sauer, and
U Lasson
February 2016,
Journal of medical imaging and radiation oncology,
G Prindull, and
H Jürgens, and
F Jentsch, and
R Sauer, and
U Lasson
June 2018,
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
G Prindull, and
H Jürgens, and
F Jentsch, and
R Sauer, and
U Lasson
October 2006,
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery,
G Prindull, and
H Jürgens, and
F Jentsch, and
R Sauer, and
U Lasson
July 2013,
EMBO molecular medicine,
G Prindull, and
H Jürgens, and
F Jentsch, and
R Sauer, and
U Lasson
April 2006,
Cancer,
